Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
The FDA announced the discontinuation of Allergan’s Byvalson (nebivolol/valsartan) tablets.
Download PDF
Return to publications
